Previously published data have shown that CD84 positively regulates LPS-induced cytokine secretion through MAPK phosphorylation and NF-κB activation in macrophages (44), 2 survival pathways that are critical to support AML progression and drug resistance (45–50). The gene discussed is NFKB1; the disease is acute myeloid leukemia.